Hydrogen Sulfide Deficiency Contributes to Tubular Damage and Calcium Oxalate Crystal Formation in Hyperoxaluria Nephropathy: Role of Osteopontin and Tamm-Horsfall Protein. [PDF]
Lu CL, Tseng YS, Wu WB, Liao CH, Ma MC.
europepmc +1 more source
Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands. [PDF]
Deesker LJ +9 more
europepmc +1 more source
Tailored Kidney Stone Prevention Improves Metabolic Risk Factors and Reduces Renal Colic Rate. [PDF]
Van de Perre E +14 more
europepmc +1 more source
Improved 24-hour urine parameters associated with reduced symptomatic kidney stone recurrence. [PDF]
Sui W +6 more
europepmc +1 more source
Gut to Stone: The Woes of Malabsorption and Kidney Stone Growth. [PDF]
Varanasi P, Yau AA, Keddis M.
europepmc +1 more source
A novel synbiotic formulation prevents calcium oxalate stones by restoring gut microbiota homeostasis. [PDF]
Li XM +9 more
europepmc +1 more source
Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world study. [PDF]
Goldfarb DS +6 more
europepmc +1 more source
Probiotics in the prevention and treatment of calcium oxalate kidney stones: mechanisms and therapeutic potential. [PDF]
Yang J, Li D, Li T, Jia B.
europepmc +1 more source

